MRP ₹63
(Inclusive of all Taxes)
₹7.6 Cashback (12%)
coupon
Prescription drugWhats That
Composition :
AMIODARONE-50MG
Manufacturer/Marketer :
Cipla Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
NPPA :
Regulated
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
_0.jpg?tr=q-85,f-webp,w-100,dpr-1,c-at_max "Santoshini Reddy G")
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Unsafe
Tachyra 50 mg Injection 3 ml may interact with alcohol and worsen liver conditions. So, it is recommended to avoid alcohol intake while on treatment with Tachyra 50 mg Injection 3 ml.
Pregnancy
Caution
Inform your doctor if you are pregnant or suspect pregnancy. Your doctor will weigh the benefits and potential risks before prescribing Tachyra 50 mg Injection 3 ml.
Breast Feeding
Unsafe
Avoid breastfeeding while on treatment with Tachyra 50 mg Injection 3 ml.
Driving
Unsafe
Tachyra 50 mg Injection 3 ml may cause vision problems and dizziness. So, avoid driving or operating heavy machinery after taking Tachyra 50 mg Injection 3 ml.
Liver
Caution
Tachyra 50 mg Injection 3 ml might affect the liver. So, if you have a history of liver diseases/conditions, inform your doctor; your doctor will assess the benefits and potential hazards.
Kidney
Caution
Tachyra 50 mg Injection 3 ml should be used with caution in persons with kidney problems. So, if you have a history of kidney disease/conditions, inform your doctor; your doctor will weigh the benefits and risks.
Children
Caution
Please consult your doctor if you have any concerns regarding the usage of Tachyra 50 mg Injection 3 ml in children.
Product Substitutes
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Dronedarone may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Dronedarone interact, it can be taken if prescribed by a doctor.If you have other cardiac disorders, or imbalances in electrolytes, you may be at greater risk. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Dronedarone may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Dronedarone interact, it can be taken if prescribed by a doctor.If you have other cardiac disorders, or imbalances in electrolytes, you may be at greater risk. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
Taking Tachyra 50 mg Injection 3 ml and Ciprofloxacin may significantly increase the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Tachyra 50 mg Injection 3 ml with Ciprofloxacin is not recommended, it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath. Do not discontinue any medications without consulting a doctor.
Taking Tachyra 50 mg Injection 3 ml and Ciprofloxacin may significantly increase the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Tachyra 50 mg Injection 3 ml with Ciprofloxacin is not recommended, it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath. Do not discontinue any medications without consulting a doctor.
AmiodaroneNelfinavir
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Nelfinavir may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Nelfinavir interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Nelfinavir may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Nelfinavir interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Thioridazine may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Thioridazine with Tachyra 50 mg Injection 3 ml is not recommended, please consult your doctor before taking it.
The combination of Tachyra 50 mg Injection 3 ml and Thioridazine may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Thioridazine with Tachyra 50 mg Injection 3 ml is not recommended, please consult your doctor before taking it.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Fingolimod may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Fingolimod interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Fingolimod may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Fingolimod interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Ofloxacin may significantly increase the risk of an abnormal heart rhythm.
How to manage the interaction:
Although Tachyra 50 mg Injection 3 ml and Ofloxacin interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without consulting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Ofloxacin may significantly increase the risk of an abnormal heart rhythm.
How to manage the interaction:
Although Tachyra 50 mg Injection 3 ml and Ofloxacin interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without consulting a doctor.
AmiodaroneEliglustat
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Eliglustat may increase the risk of an irregular heartbeat considerably.
How to manage the interaction:
Even though Tachyra 50 mg Injection 3 ml and Eliglustat interact, it can be taken if prescribed by a doctor. Consult a doctor if you have abrupt dizziness, lightheadedness, fainting, shortness of breath, slow heart rate, weak pulse, or heart palpitations. Do not discontinue any medications without consulting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Eliglustat may increase the risk of an irregular heartbeat considerably.
How to manage the interaction:
Even though Tachyra 50 mg Injection 3 ml and Eliglustat interact, it can be taken if prescribed by a doctor. Consult a doctor if you have abrupt dizziness, lightheadedness, fainting, shortness of breath, slow heart rate, weak pulse, or heart palpitations. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Sparfloxacin may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Sparfloxacin interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Sparfloxacin may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Sparfloxacin interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
Taking Tachyra 50 mg Injection 3 ml and Moxifloxacin may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Tachyra 50 mg Injection 3 ml and Moxifloxacin is not recommended as it can lead to an interaction; it can be taken if advised by a doctor. If you get dizziness, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Taking Tachyra 50 mg Injection 3 ml and Moxifloxacin may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Taking Tachyra 50 mg Injection 3 ml and Moxifloxacin is not recommended as it can lead to an interaction; it can be taken if advised by a doctor. If you get dizziness, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor.
Critical
How does the drug interact with Tachyra 50 mg Injection 3 ml:
The combination of Tachyra 50 mg Injection 3 ml and Cisapride may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Cisapride interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor. Note: Cisapride is no longer available on the market. Cisapride should only be used under the supervision of a doctor.
The combination of Tachyra 50 mg Injection 3 ml and Cisapride may significantly raise the risk of an abnormal heart rhythm.
How to manage the interaction:
Despite the fact that Tachyra 50 mg Injection 3 ml and Cisapride interact, it can be taken if prescribed by a doctor. If you get dizziness, lightheadedness, fainting, or fast or racing heartbeats, consult a doctor. Do not stop taking any medications without visiting a doctor. Note: Cisapride is no longer available on the market. Cisapride should only be used under the supervision of a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
AMIODARONE-50MGCare involving dialysis
Severe
AMIODARONE-50MGOther chronic obstructive pulmonary disease
Severe
Drug-Diseases Interactions
Login/Sign Up
AMIODARONE-50MGCare involving dialysis
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Tachyra 50 mg Injection 3 ml and its active metabolite are not removed by hemodialysis.
How to manage the interaction:
Patients receiving dialysis are not advised to use Tachyra 50 mg Injection 3 ml because it can be eliminated during the procedure. Dialysis should be secluded before taking the Tachyra 50 mg Injection 3 ml dose. Do not discontinue any medications without first consulting your doctor.
Tachyra 50 mg Injection 3 ml and its active metabolite are not removed by hemodialysis.
How to manage the interaction:
Patients receiving dialysis are not advised to use Tachyra 50 mg Injection 3 ml because it can be eliminated during the procedure. Dialysis should be secluded before taking the Tachyra 50 mg Injection 3 ml dose. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther chronic obstructive pulmonary disease
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Tachyra 50 mg Injection 3 ml should be administered caution in patient with pulmonary dysfunction.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy can increase the risk or severity of lung toxicity in patients with a history of lung disease. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. Contact your doctor immediately if you experience symptoms like difficulty or discomfort in breathing, shortness of breath, or palpitations.
Tachyra 50 mg Injection 3 ml should be administered caution in patient with pulmonary dysfunction.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy can increase the risk or severity of lung toxicity in patients with a history of lung disease. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. Contact your doctor immediately if you experience symptoms like difficulty or discomfort in breathing, shortness of breath, or palpitations.
AMIODARONE-50MGShock, not elsewhere classified
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
The use of Tachyra 50 mg Injection 3 ml is contraindicated for use in patients with cardiogenic shock, severe sinus node dysfunction causing marked sinus bradycardia, second- or third-degree AV block, or symptomatic bradycardia in the absence of a functioning pacemaker.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with a history of heart disease as it can increase the risk or severity. However, Tachyra 50 mg Injection 3 ml therapy can be taken if prescribed by your doctor. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, or rapid heartbeat, contact your doctor immediately.
The use of Tachyra 50 mg Injection 3 ml is contraindicated for use in patients with cardiogenic shock, severe sinus node dysfunction causing marked sinus bradycardia, second- or third-degree AV block, or symptomatic bradycardia in the absence of a functioning pacemaker.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with a history of heart disease as it can increase the risk or severity. However, Tachyra 50 mg Injection 3 ml therapy can be taken if prescribed by your doctor. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, or rapid heartbeat, contact your doctor immediately.
AMIODARONE-50MGVisual impairment including blindness (binocular or monocular)
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Optic neuropathy and/or neuritis has occurred during administration of Tachyra 50 mg Injection 3 ml and has resulted in visual impairment such as changes in visual acuity, decrease in peripheral vision, and blindness.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with visual defects as it can increase the severity of nerve inflammation, visual disturbances, decreased vision, and blindness. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience vision loss, loss of color vision, tunnel vision, or difficulty seeing at night, contact your doctor immediately.
Optic neuropathy and/or neuritis has occurred during administration of Tachyra 50 mg Injection 3 ml and has resulted in visual impairment such as changes in visual acuity, decrease in peripheral vision, and blindness.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with visual defects as it can increase the severity of nerve inflammation, visual disturbances, decreased vision, and blindness. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience vision loss, loss of color vision, tunnel vision, or difficulty seeing at night, contact your doctor immediately.
AMIODARONE-50MGComplications and ill-defined descriptions of heart disease
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Antiarrhythmic agents should be administered caution and dosage and frequency of administration modified in patients with hypotension or adequately compensated CHF.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with heart disease as it can increase the risk or severity of low blood pressure and heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Antiarrhythmic agents should be administered caution and dosage and frequency of administration modified in patients with hypotension or adequately compensated CHF.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with heart disease as it can increase the risk or severity of low blood pressure and heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther cardiac arrhythmias
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
antiarrhythmics should be used with extreme caution in patients with or predisposed to arrhythmias.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with abnormal heartbeats as it can increase the risk or severity of heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
antiarrhythmics should be used with extreme caution in patients with or predisposed to arrhythmias.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with abnormal heartbeats as it can increase the risk or severity of heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther cardiac arrhythmias
Severe
How does the disease interact with Tachyra 50 mg Injection 3 ml:
The use of certain antimalarial agents is contraindicated in patients with known prolongation of QT interval as these patients can develop fatal arrhythmias.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with abnormal heart rhythms as it can increase the risk or severity of heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
The use of certain antimalarial agents is contraindicated in patients with known prolongation of QT interval as these patients can develop fatal arrhythmias.
How to manage the interaction:
Tachyra 50 mg Injection 3 ml therapy is not advised in patients with abnormal heart rhythms as it can increase the risk or severity of heart functions. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, palpitations, chest pain or discomfort, or rapid heartbeat, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGHepatic failure, not elsewhere classified
Moderate
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Tachyra 50 mg Injection 3 ml should not be used in hepatic impairment patients.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with liver disease as it can increase the risk or severity of liver injury. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience nausea, vomiting, stomach pain or discomfort, yellowing of skin or eyes, or sleeplessness contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Tachyra 50 mg Injection 3 ml should not be used in hepatic impairment patients.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with liver disease as it can increase the risk or severity of liver injury. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience nausea, vomiting, stomach pain or discomfort, yellowing of skin or eyes, or sleeplessness contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther symptoms and signs involving the nervous and musculoskeletal systems
Moderate
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Tachyra 50 mg Injection 3 ml should be administered caution and dosage modifications considered in patients with neurologic dysfunction.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with neurologic disorders as it can increase the risk or severity of nerve injury. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience dizziness, tongue numbness, visual impairment or disturbances, lack of coordination, or muscular twitching contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Tachyra 50 mg Injection 3 ml should be administered caution and dosage modifications considered in patients with neurologic dysfunction.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with neurologic disorders as it can increase the risk or severity of nerve injury. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience dizziness, tongue numbness, visual impairment or disturbances, lack of coordination, or muscular twitching contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther disorders of thyroid
Moderate
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Tachyra 50 mg Injection 3 ml should be administered cautiously in patients with thyroid dysfunction.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with thyroid disorders as it can reduce the production of thyroid hormone leading to increased severity. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience tiredness, weight gain, depression, restlessness, frequent and heavy menstrual periods, or intolerance to cold temperatures contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Tachyra 50 mg Injection 3 ml should be administered cautiously in patients with thyroid dysfunction.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with thyroid disorders as it can reduce the production of thyroid hormone leading to increased severity. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience tiredness, weight gain, depression, restlessness, frequent and heavy menstrual periods, or intolerance to cold temperatures contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
AMIODARONE-50MGOther disorders of fluid, electrolyte and acid-base balance
Moderate
How does the disease interact with Tachyra 50 mg Injection 3 ml:
Electrolyte imbalance can alter the therapeutic effectiveness of antiarrhythmic agents. Hypokalemia and hypomagnesemia can reduce the effectiveness of antiarrhythmic agents.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with electrolyte imbalance as this can reduce the effectiveness of Tachyra 50 mg Injection 3 ml. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience tiredness, fatigue, palpitations, shortness of breath, chest pain, nausea, or vomiting contact your doctor immediately. Make sure to rehydrate yourself while taking Tachyra 50 mg Injection 3 ml therapy. Do not discontinue any medications without first consulting your doctor.
Electrolyte imbalance can alter the therapeutic effectiveness of antiarrhythmic agents. Hypokalemia and hypomagnesemia can reduce the effectiveness of antiarrhythmic agents.
How to manage the interaction:
Although it is a rare adverse effect, Tachyra 50 mg Injection 3 ml therapy is not advised in patients with electrolyte imbalance as this can reduce the effectiveness of Tachyra 50 mg Injection 3 ml. Tachyra 50 mg Injection 3 ml therapy can be taken if your doctor has advised it. If you experience tiredness, fatigue, palpitations, shortness of breath, chest pain, nausea, or vomiting contact your doctor immediately. Make sure to rehydrate yourself while taking Tachyra 50 mg Injection 3 ml therapy. Do not discontinue any medications without first consulting your doctor.
Tachyra 50 mg Injection 3 ml Substitute
Have a query?